BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Glutenostics Launches Gluten Detective, the First at-Home Gluten Consumption Monitoring Test

  In just 15 minutes or more, in the privacy of a bathroom anywhere in the world, people are now able to sample their urine or stool to detect gluten fragments indicative of gluten consumption over the previous 1-2 or more days.

  November 6, 2017

   · 

  2 min read
• Business

  Evotec Joins Forces With Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build ‘NEPLEX’

  The goal of the NEPLEX consortium is to develop a functional Nephron-on-a-Chip that reflects both the filtration area as well as the resorption area of a human kidney.

  November 6, 2017

   · 

  7 min read
• West to Showcase New Extensions of the SmartDose Drug Delivery Platform at the PDA Universe of Pre-Filled Syringes and Injection Devices

  West’s SmartDose drug delivery platform allows patients to self-administer medication in accordance with their prescribed treatment.

  November 6, 2017

   · 

  6 min read
• Drug Development

  Biohaven Doses First Subject in Pivotal Bioequivalence Study With Sublingual BHV-0223

  Biohaven is developing BHV-0223, a sublingual formulation of riluzole, as a potential treatment for patients with ALS.

  November 6, 2017

   · 

  4 min read
• Drug Development

  AVEO Oncology and EUSA Pharma Announce Promising Phase I Results From the Phase I/II TiNivo Study of Tivozanib and Nivolumab in Renal Cell Carcinoma

  No grade 4 adverse events were reported.

  November 6, 2017

   · 

  8 min read
• Notice of EGM in Karolinska Development AB

  The shareholders of Karolinska Development AB are invited to the Extraordinary General Meeting on Tuesday November 28, 2017 at 16:00 (CET), at Tomtebodavagen 23 A in Solna, Sweden.

  November 6, 2017

   · 

  6 min read
• Pharmaleads CEO to Present at Bio-Europe 2017

  This year’s BIO-Europe conference will take place from 6-8 November at CityCube in Berlin, Germany.

  November 6, 2017

   · 

  1 min read
• Drug Development

  Debiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors Including NSCLC

  The trial is being conducted under a clinical collaboration agreement announced last year between Debiopharm International SA and the Merck-Pfizer Alliance.

  November 6, 2017

   · 

  5 min read
• 

  Neovasc Jumps on FDA Nod for Clinical Trial

  The trial’s purpose will be to demonstrate the safety and effectiveness of the Company’s novel Reducer system for treatment of patients with refractory angina.

  November 6, 2017

   · 

  7 min read
• Business

  STORM Therapeutics Strengthens Board With Appointment of Professor Paul Workman, President and CEO of the Institute of Cancer Research

  This appointment continues STORM’s evolution of its management and advisory networks as it fulfils its ambition to become the leading therapeutics company in RNA epigenetic modulation.

  November 6, 2017

   · 

  1 min read